Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibition

Rauh-Hain, Jose

392
Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibition

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

J. A. Rauh-Hain¹, M. Kim², L. Zhang², R. Foster², B. R. Rueda², M. Bhasin³ and W. B. Growdon¹
¹Massachusetts General Hospital/Harvard University, Boston, MA, ²Massachusetts General Hospital, Boston, MA, ³Beth Israel Deaconess Medical Center, Boston, MA

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

392
Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibition

392 Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibition

392
Next-generation sequencing demonstrates genomic signature of resistance patterns following phosphatidylinositol 3-kinase (PI3K) inhibition